Manulife's Core Earnings Beat Ignored as Biases Keep Stock 10% Undervalued

Manulife delivered a clear financial catalyst last week. The company's fourth-quarter core earnings per share of $1.12 smashed analyst forecasts by nearly 47%. For the full year, core EPS grew 8%, a solid beat that underscored operational execution. Yet the stock's reaction was muted, showing a slight premarket decline and closing at $37.80. This disconnect between a strong beat and a weak price move sets up the central puzzle.

The analyst consensus paints a stark contrast. Despite the tepid market response, the stock carries a consensus "Buy" rating with an average twelve-month price target of $51.50. That implies a significant discount to perceived fair value, with some estimates suggesting the market is pricing the stock around 10% below its intrinsic worth. The setup is classic behavioral finance: a company beats expectations, but the market's sentiment remains anchored to broader fears or past performance, refusing to fully price in the improvement.

This is where psychology takes over from the numbers. The market's slight premarket decline, even after such a large beat, hints at a deeper cognitive bias at play. Investors may be exhibiting sectoral caution and broader market uncertainties, allowing these macro fears to override a clear company-specific positive. The result is a market that is slow to update its valuation, a phenomenon often driven by loss aversion and recency bias. In other words, the market is discounting a good quarter because it is still focused on the bad year, or the bad sector, or the bad news cycle. The puzzle is not the beat itself, but why the market's reaction is so muted.

Behavioral Biases in Action: Why the Bull Case is Being Overlooked

Investors may benefit from evaluating the stock from a quantitative perspective as well. This could provide additional insights into the stock's price behavior independent of sentiment-driven factors.

First, loss aversion is making investors overly sensitive to declines. The headline numbers show a $1.5 billion in net income, down from the prior year. This triggers a psychological pain response that can overshadow the more relevant operational metric: core earnings rose 5%. The market is also fixated on the $9.5 billion in net outflows from its wealth management unit. This focus on the loss in net income and the outflows creates a negative anchor, making it difficult for investors to fully appreciate the underlying 8% core EPS growth for the year and the strong performance in key segments like Asia.

Second, recency bias is amplifying the negative impact of recent quarterly events. The market is giving disproportionate weight to the $232 million charge in its Alternative Long-Duration Assets portfolio and the 22% decline in core earnings from the US segment. These recent, specific hits are vivid and emotionally resonant, crowding out the longer-term narrative of operational momentum. This is classic recency bias: the most recent bad news is perceived as more indicative of future performance than the broader, more positive trend.

Finally, confirmation bias is locking investors into a negative narrative. The market is fixating on the 17-per-cent discount to banks on a forward P/E basis. This valuation metric supports the prevailing bearish view. Yet, analysts point to countervailing strengths: greater capital flexibility, lower downside risk, and a clear path to an 18%-plus core ROE by 2027. The confirmation bias loop works like this: the low P/E confirms the stock is cheap, which reinforces the view that it should stay cheap, causing investors to ignore the catalysts that could close the gap.

The bottom line is that these biases are creating a distorted lens. The market is seeing a company with a strong year and a clear beat, but its psychology is stuck on the losses, the recent charges, and the low valuation. This is why the stock trades at a discount to its intrinsic worth, even as the fundamentals improve. The bull case is being overlooked not because it lacks merit, but because human behavior is systematically discounting it.

The Strategic Reality vs. The Sentiment Gap

The market's sentiment is stuck in the past, fixated on losses and outflows. Yet Manulife's operational reality is one of clear momentum and tangible shareholder benefits. The disconnect lies in the gap between these concrete positives and the prevailing negative narrative.

First, look at the growth engine. The company's Asia segment continued to be a strong growth driver, with adjusted earnings rising 24% from a year ago. This isn't a one-quarter flash; it's a multi-quarter trend that powered the company's record core earnings and insurance new business results for 2025. This segment is the primary reason for the year's overall 8% core EPS growth and is a key reason analysts expect to raise their fair value estimate. Yet, the market's focus on the US segment's headwinds and the global wealth unit's outflows drowns out this clear, positive signal.

Second, the company is generating substantial cash for shareholders. Manulife reported remittances from operating units totaling $6.4 billion in 2025. This robust cash flow supports a capital return policy targeting 65-75% of adjusted earnings. In practice, the company returned around C$5.4 billion to shareholders via dividends and buybacks in 2025, equivalent to about 72% of core earnings. This is a tangible, recurring benefit that strengthens the investment case. The market's discount, however, seems to ignore this reliable capital return stream, focusing instead on the headline net income decline.

Finally, the company's financial buffer is robust. Manulife maintains a strong LICAT ratio of 136% at year-end. This capital adequacy provides a significant safety net, reducing the perceived risk of its operations. Yet, this fundamental strength is not being reflected in the valuation. The stock trades at a 17-per-cent discount to banks on a forward P/E basis, a multiple that fails to account for the company's capital flexibility and lower downside risk.

The bottom line is that these are not abstract metrics. They are the pillars of a company executing its strategy, growing in key markets, returning cash, and maintaining a solid balance sheet. The market's sentiment, however, is being driven by loss aversion and recency bias, fixating on the recent $232 million charge and the $9.5 billion in wealth outflows. This creates a persistent gap: the strategic reality is one of momentum and shareholder value, while the sentiment gap keeps the stock priced for underperformance.

Catalysts and Risks: What Could Close the Sentiment Gap

The market's discount to Manulife's intrinsic value is a sentiment gap, not a permanent valuation. The path to closing it hinges on a few forward-looking events and metrics that could shift the narrative from one of lingering headwinds to one of tangible improvement.

The most immediate catalyst is the anticipated "release" phase of the US stop-loss reserving cycle in 2026. As TD Cowen analyst Mario Mendonca notes, SLF is expected to report more modest experience losses in U.S. and point to a better result in 2026. This cycle, which has pressured earnings in recent quarters, is now seen as entering a phase where the company can report a cleaner, less volatile result. For Manulife, this could mean the US segment's core earnings decline stabilizes or reverses, directly challenging the negative anchor of recent quarterly performance.

Investors should monitor two key metrics for signs of stabilization. First is the trajectory of the $9.5 billion in net outflows from the Global Wealth & Asset Management unit. While large redemptions have been a drag, the focus will be on whether net flows begin to turn positive or at least narrow materially. Second, the performance of the Alternative Long-Duration Asset portfolio is critical. The $232 million charge last quarter was a specific hit; consistent improvement here would signal the portfolio is weathering its challenges and no longer a source of recurring surprise.

Finally, a technical signal to watch is the stock's momentum. Manulife's Relative Strength (RS) Rating recently moved to the 73rd percentile. This is a positive technical indicator, suggesting the stock is outperforming a significant portion of the market on price action. If this momentum holds and builds on the fundamental catalysts, it could serve as a powerful feedback loop, attracting more investors and accelerating the sentiment shift.

The bottom line is that the market's discount is a bet on continued trouble. Each of these forward-looking factors represents a potential validation of the bullish analyst view. A cleaner US result, stabilizing wealth outflows, a recovering ALD portfolio, and sustained technical strength could collectively close the gap between the company's operational reality and its market price.